High PXN expression levels were observed in UVM (66.7%), thyroid carcinoma (54%), testicular germ cell tumors (41.7%), GBM (27.3%), HNSC (25%), ovarian cancer (25%), PRAD (18.2%), DLBC (16.7%), SKCM (16.7%), COAD (10%), BLCA (9.1%), and BRCA (9.1%) (Figure 6). Here, PXN is linked to glioblastoma.